|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/4166 | (2013.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61K 47/32 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/4166 | (2006.01) | ||
| A61K 9/2027 | (2013.01) | ||
| A61P 13/08 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3616696 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18791486.6 |
| Europos patento paraiškos padavimo data | 2018-04-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-03-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-03-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2018/017159 |
| Data | 2018-04-27 |
| (87) | Numeris | WO 2018/199282 |
| Data | 2018-11-01 |
| (30) | Numeris | Data | Šalis |
| 2017090300 | 2017-04-28 | JP |
| (72) |
UMEMOTO, Yoshiaki , JP
YOSHIDA, Takatsune , JP
NAMIKI, Sachie , JP
TAKAGI, Akira , JP
KOJIMA, Ryo , JP
SAKAI, Toshiro , JP
OBA, Shinsuke , JP
AOKI, Hajime , JP
|
| (73) |
Astellas Pharma Inc. ,
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411,
JP
|
| (54) | ORALLY ADMINISTRABLE ENZALUTAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION |
| ORALLY ADMINISTRABLE ENZALUTAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION |